Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sotac Pharmaceuticals Ltd

SOTAC.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.92

▲ +0.00%

Market Cap $10.12M · Vol 1.20K

Key Metrics

P/E Ratio

16.74

FWD: N/A

Market Cap

$10.12M

Micro Cap

Div Yield

0.11%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

14.35

Momentum

Beta

0.95

vs Market

52W High

$1.46

41.69% below

52W Low

$0.90

1.56% above

Volume

1.20K

Avg 4.56K

P/B

2.05

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sotac Pharmaceuticals Ltd (SOTAC.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SOTAC.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.95%

-12.60%

-21.47%

-30.08%

YTD

-29.00%

-30.08%

-35.65%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$10.83M
Net Income	$673.39K
Revenue Growth (YoY)	N/A
Gross Margin	30.94%
Operating Margin	12.32%
Net Profit Margin	6.22%
ROE	N/A
ROA · ROIC	6.75% · 8.57%

P/E Ratio	16.74
Forward P/E (FY1)	N/A
PEG Ratio	-0.74
P/S	1.19
P/B	2.05
P/FCF	24.65
EPS Growth	N/A
Outstanding Shares	11.05M

Technical Indicators

50-Day SMA	$1.05
200-Day SMA	$1.18
RSI (14)	14.35
Beta	0.95
52-Week High	$1.46
52-Week Low	$0.90

Volume Today	1.20K
Avg Daily Volume (30D)	4.56K
Relative Volume	0.26x
Volatility (10D)	24.07
Volatility (30D)	26.45
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.92

Mean Target N/A

52W Low$0.90 52W High$1.46

Current

Target

$0.90 $1.46

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG01G3R8Z95

ISININE0O2D01012

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Sotac Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company manufactures pharmaceutical products such as tablets, capsules (general & beta-lactum), oral liquid, dry syrup and external preparations. Its services include contract manufacturing, loan license, formulation and development (F&D) and research and development (R&D). Its products portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacids, anti-ulcerants, proton pump inhibitors (PPIs), anti-emetics, cardiac care, anti-hypertensives, analgesics, anti-pyretics, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal, and cephalosporin products. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Research Private Limited, and Sotac Lifesciences Private Limited.